The immunogenicity of fractional (one-fifth, 0.1 mL) intradermal doses of the inactivated poliovirus vaccine (ID fIPV) is positively correlated with the size of the intradermal fluid bleb. Training of vaccinators for campaign and routine ID fIPV administration should focus on generating an 8- to 10-mm bleb with each injection. Clinical Trials Registration NCT01847872
AbstractOne option for achieving global polio eradication is to replace the oral poliovirus vaccine ...
The polio eradication endgame aims to bring transmission of all polioviruses to a halt. To achieve t...
Background: Administration of intradermal fractional dose of inactivated poliovirus vaccine (fIPV) h...
The immunogenicity of fractional (1/5th, 0.1mL) intradermal doses of the inactivated poliovirus vacc...
A fractional dose of inactivated poliovirus vaccine (fIPV) administered by the intradermal route del...
SummaryObjectiveComparison of a fractional inactivated poliovirus vaccine (IPV) dose administered in...
Administration of 1/5th dose of Inactivated poliovirus vaccine intradermally (fIPV) provides similar...
Background: The introduction of the inactivated poliovirus vaccine (IPV) represents a crucial ste...
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compar...
Purpose: The aim of this study was to investigate the depth-dependent intradermal immunogenicity of ...
Background: Fractional dose (1/5th of full intramuscular dose) of inactivated poliovirus-vaccine adm...
(See the editorial commentary by Hull and Minor and the article by Hennessey et al., on pages 2033–5...
The purpose of this study was to investigate the effect of various repeated fractional intradermal d...
Background. The World Health Organization has recommended that all 124 countries currently using onl...
The purpose of this study was to investigate the effect of various repeated fractional intradermal d...
AbstractOne option for achieving global polio eradication is to replace the oral poliovirus vaccine ...
The polio eradication endgame aims to bring transmission of all polioviruses to a halt. To achieve t...
Background: Administration of intradermal fractional dose of inactivated poliovirus vaccine (fIPV) h...
The immunogenicity of fractional (1/5th, 0.1mL) intradermal doses of the inactivated poliovirus vacc...
A fractional dose of inactivated poliovirus vaccine (fIPV) administered by the intradermal route del...
SummaryObjectiveComparison of a fractional inactivated poliovirus vaccine (IPV) dose administered in...
Administration of 1/5th dose of Inactivated poliovirus vaccine intradermally (fIPV) provides similar...
Background: The introduction of the inactivated poliovirus vaccine (IPV) represents a crucial ste...
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compar...
Purpose: The aim of this study was to investigate the depth-dependent intradermal immunogenicity of ...
Background: Fractional dose (1/5th of full intramuscular dose) of inactivated poliovirus-vaccine adm...
(See the editorial commentary by Hull and Minor and the article by Hennessey et al., on pages 2033–5...
The purpose of this study was to investigate the effect of various repeated fractional intradermal d...
Background. The World Health Organization has recommended that all 124 countries currently using onl...
The purpose of this study was to investigate the effect of various repeated fractional intradermal d...
AbstractOne option for achieving global polio eradication is to replace the oral poliovirus vaccine ...
The polio eradication endgame aims to bring transmission of all polioviruses to a halt. To achieve t...
Background: Administration of intradermal fractional dose of inactivated poliovirus vaccine (fIPV) h...